Locations:
February 17, 2026/News Updates

Cleveland Clinic First Hospital in the U.S. To Perform Robotic-Assisted Prostate Surgery Using Newly FDA-Cleared System

Cleveland Clinic is first health system in U.S. to use new robotic-assisted surgery system for prostatectomy

Media Contact

Hope Buggey | 216.213.6192

Media Downloads

Content is property of Cleveland Clinic and for news media use only.

Hugo robot

Following the recent U.S. Food and Drug Administration’s approval in December 2025, Cleveland Clinic is the first health system in the U.S. to use a new robotic-assisted surgery system for a prostatectomy.

The new robotic system features modular “arms” that allow the surgeon to choose the best angle while operating on the patient, as well as an open console where the surgeon sits to operate the foot pedals and hand controls. This allows the surgeon to focus on the surgery as well as be aware of their surroundings.

The benefits of minimally invasive robotic surgery include reduced blood loss, shorter hospital stays, decreased recovery time and less postoperative pain for patients.

The FDA approval followed data from the Expand URO investigational device exemption clinical study — the largest ever completed for multi-port robotic-assisted urological surgery in the U.S., led by Dr. Jihad Kaouk, who was the principal investigator. Expand URO demonstrated that the system, called the Hugo RAS, met primary safety and effectiveness endpoints in urologic surgical procedures.

“This case exemplifies Cleveland Clinic's mission to lead surgical innovation and expand access to minimally invasive surgery for patients," said Dr. Kaouk, M.D., Professor and Chair, Glickman Urologic Institute and Zegarac-Pollock Endowed Chair in Robotic Surgery. “The potential for this new technology extends beyond urology to other specialties, and we look forward to building our experience with this new system and exploring the added benefit for patients.”

Latest from the Newsroom

Lobby of new Toronto location

Cleveland Clinic Canada Moves to New Downtown Toronto Location

Artist's rendering of gene therapy for high triglycerides.

Gene Editing Therapy Trial Dramatically Lowers Dangerous Blood Fat Levels

Artist's illustration of gene editing

Cleveland Clinic First-in-Human Trial Shows Gene-Silencing Therapy for High Cholesterol to Be Safe and Effective

Medical illustration of lipoprotein(a) molecule

Cleveland Clinic Trial Shows Novel Lipoprotein(a) Drug Did Not Reduce Major Cardiovascular Events After Nearly 5 Years

Ali Aminian, M.D., performing bariatric surgery.

Cleveland Clinic Study Finds Bariatric Surgery Effective for Substantial Weight Loss After GLP-1 Intolerance or Limited Weight Loss

Eric Boose, M.D., uses AI software to document a patient appointment.

Newsweek Ranks Cleveland Clinic Among World's Best Smart Hospitals

Graphic representing cardiomyopathy and DNA

Cleveland Clinic-led Study Establishes Major Genetic Contributor to Heart Failure in People of African Ancestry

Dr Fujiki performing surgery

Cleveland Clinic First in Ohio to Perform Abdominal Tumor Removal Using Highly Specialized Surgical Technique